JP2012517225A5 - - Google Patents

Download PDF

Info

Publication number
JP2012517225A5
JP2012517225A5 JP2011549110A JP2011549110A JP2012517225A5 JP 2012517225 A5 JP2012517225 A5 JP 2012517225A5 JP 2011549110 A JP2011549110 A JP 2011549110A JP 2011549110 A JP2011549110 A JP 2011549110A JP 2012517225 A5 JP2012517225 A5 JP 2012517225A5
Authority
JP
Japan
Prior art keywords
seq
protein
sequence number
bacteriophage
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011549110A
Other languages
English (en)
Japanese (ja)
Other versions
JP5701777B2 (ja
JP2012517225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2010/000003 external-priority patent/WO2010090542A2/en
Publication of JP2012517225A publication Critical patent/JP2012517225A/ja
Publication of JP2012517225A5 publication Critical patent/JP2012517225A5/ja
Application granted granted Critical
Publication of JP5701777B2 publication Critical patent/JP5701777B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011549110A 2009-02-06 2010-02-05 抗菌性ファージ、ファージペプチド、及びそれらの使用方法 Active JP5701777B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15058509P 2009-02-06 2009-02-06
US61/150,585 2009-02-06
US21834509P 2009-06-18 2009-06-18
US61/218,345 2009-06-18
PCT/PT2010/000003 WO2010090542A2 (en) 2009-02-06 2010-02-05 Antibacterial phage, phage peptides and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015029248A Division JP6177264B2 (ja) 2009-02-06 2015-02-18 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2012517225A JP2012517225A (ja) 2012-08-02
JP2012517225A5 true JP2012517225A5 (enExample) 2013-05-02
JP5701777B2 JP5701777B2 (ja) 2015-04-15

Family

ID=42244489

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011549110A Active JP5701777B2 (ja) 2009-02-06 2010-02-05 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2015029248A Active JP6177264B2 (ja) 2009-02-06 2015-02-18 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2017083578A Active JP6355792B2 (ja) 2009-02-06 2017-04-20 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2015029248A Active JP6177264B2 (ja) 2009-02-06 2015-02-18 抗菌性ファージ、ファージペプチド、及びそれらの使用方法
JP2017083578A Active JP6355792B2 (ja) 2009-02-06 2017-04-20 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Country Status (13)

Country Link
US (2) US9134312B2 (enExample)
EP (3) EP3115054B1 (enExample)
JP (3) JP5701777B2 (enExample)
CN (2) CN105456300B (enExample)
AU (1) AU2010211456B2 (enExample)
BR (1) BRPI1008663B8 (enExample)
CA (2) CA2751641C (enExample)
ES (2) ES2761835T3 (enExample)
PL (1) PL3650034T3 (enExample)
PT (1) PT3115054T (enExample)
RU (2) RU2580248C9 (enExample)
SG (3) SG10201602330VA (enExample)
WO (1) WO2010090542A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607798D0 (en) * 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
CA2729160C (en) * 2008-07-03 2017-11-14 The Rockefeller University A chimeric bacteriophage lysin with activity against staphylococci bacteria
US8273564B2 (en) * 2009-08-12 2012-09-25 Tzu Chi Buddhist General Hospital Disinfectant composition comprising phage of Acinetobacter baumannii
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
CA3154006C (en) 2010-09-17 2025-09-09 Technophage, Investigacao E Desenvolvimento Em Biotecnologia S.A. Antibacterial phages, phage peptides and their methods of use
KR101279780B1 (ko) 2011-10-05 2013-06-28 주식회사 인트론바이오테크놀로지 액티노바실러스 플루로뉴모니애에 대한 사멸능을 갖는 박테리오파지
JP6186427B2 (ja) * 2012-03-19 2017-08-23 テクニファー−インダストリア テクニカ ファーマシューティカ,エス.エー. 抗菌性ファージのカクテルを含む組成物及び細菌感染症を処置するためのその使用
JP6250639B2 (ja) * 2012-05-04 2017-12-20 バイオコントロール リミテッドBiocontrol Limited 治療用バクテリオファージ組成物
EP2865383A1 (en) * 2013-10-25 2015-04-29 Pherecydes Pharma Phage therapy of pseudomonas infections
US9029319B1 (en) * 2014-08-04 2015-05-12 Centaur, Inc. Water buffalo derived peptide antibiotic therapies
WO2016098116A1 (en) * 2014-12-17 2016-06-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Phage therapy for targeting enterococci
CN105294840B (zh) * 2015-11-20 2018-08-17 深圳市南山区人民医院 一种用于预防和治疗肠致病大肠杆菌感染的肽段
US20170157186A1 (en) * 2015-12-02 2017-06-08 Smart Phage, Inc. Phage to treat bacteria on skin
CN105648109B (zh) * 2016-01-08 2019-04-09 河南医学高等专科学校 一种噬菌体灭菌时化学抗菌剂筛选方法
CN106699862B (zh) * 2016-11-22 2020-06-09 中国科学院海洋研究所 三种来源于脊尾白虾alf的环状多肽及其应用和抗菌剂
AU2017371484B2 (en) 2016-12-05 2022-09-15 Technophage, Investigação e Desenvolvimento Em Biotecnologia SA Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof
CA3053332A1 (en) * 2017-02-17 2018-08-23 CAMRIS International, Inc. Universal antivenom
KR101957266B1 (ko) * 2017-02-22 2019-03-13 주식회사 인트론바이오테크놀로지 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2
CN107365363B (zh) * 2017-09-20 2020-08-04 苏州大学 小分子多肽及其应用
CN107827955B (zh) * 2017-11-21 2020-05-29 苏州大学 源于分枝杆菌噬菌体多肽的衍生肽及其应用
KR20200098615A (ko) 2017-12-12 2020-08-20 콘트라펙트 코포레이션 사람 혈청의 존재하에 슈도모나스 아에루기노사에 대해 살균 활성을 갖는 리신 및 이의 유도체
EP3766967B1 (en) * 2018-03-12 2025-03-26 National University Corporation Kochi University Novel bacteriophage and treatment agent for bacterial endophthalmitis
WO2019224941A1 (ja) * 2018-05-23 2019-11-28 国立大学法人九州大学 食中毒細菌のバクテリオファージ耐性化抑制剤及びその使用
KR102131692B1 (ko) * 2018-09-11 2020-07-08 경북대학교 산학협력단 병원성 세균을 효과적으로 사멸시키는 재조합 항균 효소 LysSAP26의 용도
RU2703043C1 (ru) * 2018-09-20 2019-10-15 Наталия Петровна Антонова Литический фермент бактериофага и антибактериальная композиция на его основе
KR102193495B1 (ko) * 2018-12-26 2020-12-22 주식회사 옵티팜 신규한 아시네토박터 바우마니 균 특이 박테리오파지 ab63 및 이를 포함하는 항균 조성물
EP3946609A4 (en) * 2019-04-05 2023-05-03 Contrafect Corporation LYSINE AND ITS DERIVATIVES WITH BACTERICIDAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA IN THE PRESENCE OF HUMAN SERUM
WO2020207884A1 (en) * 2019-04-09 2020-10-15 Unilever N.V. An antimicrobial composition for selective lysis of s. hominis bacteria
US12396460B2 (en) * 2019-06-17 2025-08-26 Precisio Biotix Therapeutics, Inc. Bacterial control through dispersion of bacteriophage powders
RU2717435C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 326 (500320), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717451C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 323 (500317), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717972C1 (ru) * 2019-06-28 2020-03-27 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 324 (500318), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717026C1 (ru) * 2019-06-28 2020-03-17 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 325 (500319), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717973C1 (ru) * 2019-06-28 2020-03-27 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 322 (500316), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717022C1 (ru) * 2019-06-28 2020-03-17 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 328 (500322), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
RU2717420C1 (ru) * 2019-06-28 2020-03-23 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Штамм бактериофага Pseudomonas aeruginosa N 327 (500321), предназначенный для приготовления моно- и поливалентных лечебно-профилактических препаратов бактериофагов
CN110499266B (zh) * 2019-08-05 2021-04-27 昆明理工大学 一株粪肠球菌及其应用
US20210187046A1 (en) 2019-12-19 2021-06-24 Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa Cocktail compositions comprising respiratory antibacterial phages and methods of use thereof
CN113214364B (zh) * 2020-01-21 2022-11-22 天津大学 一种多重耐药鲍曼不动杆菌识别元件的挖掘与验证
US20230077209A1 (en) * 2020-02-14 2023-03-09 William Colton Bacteriophage Cocktail-Containing Hydrogel Compositions and Methods of Production and Use Thereof
KR102604590B1 (ko) * 2020-09-28 2023-11-23 경북대학교 산학협력단 아시네토박터 바우마니에 대한 사멸능을 가지는 박테리오파지 및 이를 포함하는 조성물
CN116514935B (zh) * 2021-03-04 2024-04-30 西部(重庆)科学城种质创制大科学中心 RNA编辑系统的抑制剂AcrIIIA1IPLA35及其应用
WO2023113396A1 (ko) * 2021-12-14 2023-06-22 경북대학교 산학협력단 클로스트리듐 디피실 세균을 효과적으로 사멸시키는 재조합 항균 단백질의 용도
CN114703173B (zh) * 2022-03-18 2023-06-06 福建省农业科学院农业质量标准与检测技术研究所 一种λ噬菌体DNA提取试剂盒及提取方法
CN114807106B (zh) * 2022-04-25 2023-09-01 昆明市延安医院 一种裂解酶pEf51和穿孔素蛋白pEf191的应用
WO2024115430A1 (en) * 2022-11-28 2024-06-06 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Acinetobacter baumannii phages
WO2024238999A2 (en) * 2023-05-17 2024-11-21 The Regents Of The University Of California Phage therapy for alcohol-associated hepatitis
CN118109445A (zh) * 2024-03-22 2024-05-31 广西中医药大学 一种耐甲氧西林金黄色葡萄球菌噬菌体裂解酶LysLP-122及其制备方法和应用
DE102024113842A1 (de) 2024-05-16 2025-11-20 bifa Umweltinstitut GmbH Verfahren zur Verringerung der bakteriellen Last auf bzw. in einer Klimaanlage
CN119162119B (zh) * 2024-07-09 2025-09-05 深圳先进技术研究院 Kl2型鲍曼不动杆菌噬菌体及其筛选方法、噬菌体组合物及应用与药物
CN118787727B (zh) * 2024-08-26 2025-03-11 中国科学院南海海洋研究所 一种清除铜绿假单胞菌的多肽及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
GB9712663D0 (en) * 1997-06-16 1997-08-20 Borealis As Process
US20060292135A1 (en) * 1997-10-31 2006-12-28 Lawrence Loomis Use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
AU4971900A (en) * 1999-05-13 2000-12-05 Exponential Biotherapies, Inc. Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium
AU2001249050A1 (en) 2000-01-11 2001-07-24 Intralytix, Inc. Reduction in bacterial colonization by administering bacteriophage compositions
RU2186574C1 (ru) * 2001-01-24 2002-08-10 Яфаев Рауэль Хасанянович Препарат поливалентного бактериофага против синегнойной палочки, штаммы бактериофага bacteriophagum pseudomonas aeruginosa спбгма им. и.и. мечникова №05, №03, №06 и №07, используемые при приготовлении поливалентного препарата против синегнойной палочки
DK1504088T3 (da) * 2002-03-25 2007-12-17 Univ Warwick Bakteriofager egnede til behandling og forebyggelse af bakterielle infektioner
US7588929B2 (en) * 2002-12-09 2009-09-15 Phage Biopharm Llc Production of bacteriophage compositions for use in phage therapy
CN101003793A (zh) * 2007-01-11 2007-07-25 中国人民解放军第三军医大学 噬菌体对环境中致病菌的净化技术
PL215522B1 (pl) 2008-09-29 2013-12-31 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
JP5732397B2 (ja) * 2008-10-10 2015-06-10 ルソメディカメンタ, エス.エー.Lusomedicamenta, S.A. 抗菌性ファージペプチド及びその使用法
KR20100093626A (ko) 2009-02-17 2010-08-26 서강대학교산학협력단 슈도모나스 애루지노사에 대한 파아지 치료
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o

Similar Documents

Publication Publication Date Title
JP2012517225A5 (enExample)
RU2014127987A (ru) Бактериофаги, белки бактериофагов и способы их применения
JP2013541333A5 (enExample)
Hirsch et al. Enhanced susceptibility to infections in a diabetic wound healing model
Serra et al. Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus
Madhusudhan Efficacy of 1% acetic acid in the treatment of chronic wounds infected with Pseudomonas aeruginosa: prospective randomised controlled clinical trial
RU2654596C2 (ru) Композиции коктейля, содержащие антибактериальные фаги, и способы их применения
Birnbach et al. Comparison of povidone iodine and DuraPrep, an iodophor-in-isopropyl alcohol solution, for skin disinfection prior to epidural catheter insertion in parturients
RU2017106290A (ru) Бактериофаги, фаговые пептиды и способы их применения
US12280080B2 (en) Antibacterial composition and uses thereof
JP2017507913A (ja) E.coli感染のファージを用いての治療
El-Gayar et al. Antivirulence and wound healing effects of royal jelly and garlic extract for the control of MRSA skin infections
Suleman et al. Biofilm-infected pressure ulcers: current knowledge and emerging treatment strategies
Kamel et al. Characterization of bee venom and its synergistic effect combating antibiotic resistance of Pseudomonas aeruginosa
US20150126571A1 (en) Method of destroying and preventing bacterial and fungal biofilm by amino acid infusion
Maslow et al. Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital
Gürgen Excess use of antibiotics in patients with non-healing ulcers.
Al-Awadi et al. Antibacterial and therapeutic effects of vancomycin-resistant Staphylococcus aureus bacteriocin (VRSAcin) in the treatment of VRSA skin infection in mice.
CN105963680A (zh) 用于抑制/瓦解生物被膜的抑制剂及其应用
Hashim et al. Assessment of Saccharomyces boulardii effect on rats Staphylococcus aureus induced skin infection: an in-vivo study
CN117138024B (zh) 一种万古霉素-抗菌肽偶合物及其应用
US11202806B2 (en) Amoeba therapeutic dressings, biomaterials, and solutions
Kolawole et al. Wound infections in two health institutions in Ile-Ife, Nigeria: results of a cohort study
Lawrence Wound infection
Bhende et al. In vitro antimicrobial effectiveness of 5 catheter insertion-site dressings